GenScript and NVIDIA Open Life Sciences AI Startup PitchFest
GenScript Biotech Corporation and NVIDIA launched a global competition for startups using AI in therapeutic discovery and life sciences, as they announced in a press release. Applications for the Life Sciences Startup PitchFest opened on October 8.
Up to six finalists will be selected in December and invited to pitch before a panel of judges during JPM Week in January. The competition covers technologies including AI based antibody and protein design, as well as tools that speed the design, build, test and learn cycle.
The winner will receive wet lab data credits from GenScript and NVIDIA Brev credits. Finalists will also receive access to GenScript validation services, NVIDIA Inception and the GenScript Biotech Global Forum.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 22 MedInTech raises $25.7 million for AI robotic endoscopes Nov 21 ModuleMD shows AI documentation, front-desk agents and skin-test measurement for allergy EHR Nov 21 Chelsea and Westminster Hospital launches multilingual AI avatar platform for lung cancer patients Nov 21 ChatGPT Health reaches Android, desktop and dots; health chats now follow the training setting Nov 20 OpenAI launches MedChemBench to test AI models on medicinal chemistry reasoningLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Switchpoint Bio raises $5.3 million for AI epigenomics platform
BioMap Announces 11 AI Life Science Collaborations
NVIDIA invests in Point2 and plans stakes in Upstage, Motif and RLWRLD
Isomorphic Labs and MSD team up to design cancer drugs with AI
Boltz raises $110 million to build AI models for drug design
Daily AI Brief: the AI news that matters, in your inbox.